Cyril Papamicael
Rouen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Redox Heterocyclic Platforms Engineered for Brain Drug Delivery and Beyond.
Journal: Chemical record (New York, N.Y.)
Published: February 10, 2026
Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases.
Journal: RSC medicinal chemistry
Published: December 12, 2023
Straightforward Access to a New Class of Dual DYRK1A/CLK1 Inhibitors Possessing a Simple Dihydroquinoline Core.
Journal: Molecules (Basel, Switzerland)
Published: November 23, 2022
Design, Synthesis, and In Vitro Biological Activities of a Bio-Oxidizable Prodrug to Deliver Both ChEs and DYRK1A Inhibitors for AD Therapy.
Journal: Molecules (Basel, Switzerland)
Published: March 04, 2019
Chemical Delivery System of MIBG to the Central Nervous System: Synthesis, 11C-Radiosynthesis, and in Vivo Evaluation.
Journal: ACS medicinal chemistry letters
Published: December 18, 2018
Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.
Journal: European journal of medicinal chemistry
Published: February 16, 2018
Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine "bio-oxidizable" prodrugs: Synthesis, biological evaluation and structure-activity relationship.
Journal: European journal of medicinal chemistry
Published: October 20, 2017
Delivering FLT to the Central Nervous System by Means of a Promising Targeting System: Synthesis, [11C]Radiosynthesis, and in Vivo Evaluation.
Journal: ACS chemical neuroscience
Published: August 09, 2017
Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation.
Journal: Journal of medicinal chemistry
Published: June 15, 2017
Dihydroquinoline Carbamate Derivatives as "Bio-oxidizable" Prodrugs for Brain Delivery of Acetylcholinesterase Inhibitors: [¹¹C] Radiosynthesis and Biological Evaluation.
Journal: ACS chemical neuroscience
Published: February 20, 2015
New developments in redox chemical delivery systems by means of 1,4-dihydroquinoline-based targetor: application to galantamine delivery to the brain.
Journal: European journal of medicinal chemistry
Published: October 22, 2013
Last Updated: 09/26/2026